» Articles » PMID: 32048263

Serotonin Discovery and Stepwise Disclosure of 5-HT Receptor Complexity over Four Decades. Part II. Some Contributions of Manfred Göthert

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2020 Feb 13
PMID 32048263
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

About 40% of the papers within the scientific oeuvre of Manfred Göthert (1939-2019) were dedicated to serotonin (5-hydroxytryptamine, 5-HT). He was not only the witness of the gradual definition of the fourteen 5-HT receptor subtypes but also was involved directly by identifying 5-HT, 5-HT and 5-HT receptors. Moreover, he identified presynaptic 5-HT receptors on central and/or peripheral serotoninergic, noradrenergic and/or cholinergic neurones. Two inhibitory (5-HT, 5-HT) and two facilitatory (5-HT, 5-HT) receptors were found, the 5-HT receptor representing a possible target for antidepressant drugs. Ten years earlier than electrophysiologists, he identified ligand-gated receptors like the 5-HT and the nicotinic acetylcholine (nACh) receptor as targets of halothane. Simultaneously with, but independent of, other authors he found that ethanol allosterically inhibits N-methyl-D-aspartate (NMDA) receptors, which are affected at an even lower concentration than 5-HT and nACh receptors. The latter two receptors were shown to be subject to allosteric inhibition also by cannabinoids via a mechanism unrelated to cannabinoid CB or CB receptors; cannabinoid inhibition of 5-HT receptors may represent a new target for the treatment of neuropathic pain.

Citing Articles

The role of 5-HT modulation in opioid withdrawal and neonatal opioid withdrawal syndrome: mechanisms and potential serotonergic targets.

Lam K, Peltz G, Kraft W Expert Opin Investig Drugs. 2025; 34(1-2):49-59.

PMID: 39900407 PMC: 11899659. DOI: 10.1080/13543784.2025.2462615.


Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system.

Cao J, Chen Z, Wang Y, Ma Y, Yang Z, Cai J Front Pharmacol. 2025; 15:1517546.

PMID: 39867657 PMC: 11759304. DOI: 10.3389/fphar.2024.1517546.


Can Serotonin 7 Receptors Be a Treatment Target for Noncentral Diseases?.

Bilgin A Eurasian J Med. 2024; 55(1):S49-S54.

PMID: 39128036 PMC: 11075038. DOI: 10.5152/eurasianjmed.2023.23303.


Tongbian formula alleviates slow transit constipation by increasing intestinal butyric acid to activate the 5-HT signaling.

Li D, Si X, Hua Y, Qian Y, Li H, Lv N Sci Rep. 2024; 14(1):17951.

PMID: 39095450 PMC: 11297216. DOI: 10.1038/s41598-024-68473-w.


Tongbian decoction restores intestinal microbiota and activates 5-hydroxytryptamine signaling: implication in slow transit constipation.

Li H, Lv N, Li D, Qian Y, Si X, Hua Y Front Microbiol. 2024; 14:1296163.

PMID: 38287961 PMC: 10822989. DOI: 10.3389/fmicb.2023.1296163.